Purpose | Board Meetings Date | Announcement Date |
---|---|---|
Board Meeting | 24 Jun 2024 | 24 Jun 2024 |
Outcome of the board meeting held on June 24, 2024 to consider and approve strategic investment (Proposed Acquisition) | ||
Board Meeting | 2 May 2024 | 22 Apr 2024 |
Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 inter alia to consider and approve Audited Financials Results for FY 2023-24 recommendation of Final Dividend and raising fund through Qualified Institutional Placement. Outcome of the Board meeting-book closure of the AGM Outcome of the Board Meeting held on Thursday, May 02, 2024, pursuant to Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Outcome of Board meeting - Board approve dividend Outcome of the Board meeting-record date for dividend Outcome of the Board meeting held on Thursday, May 02, 2024 Outcome of the Board meeting- re-appointment of Chairman & Managing Director (As Per BSE Announcement Dated on 02.05.2024) Revision in record date (As per BSE Announcement Dated on 04/05/2024) | ||
Board Meeting | 25 Jan 2024 | 15 Jan 2024 |
Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2024 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on January 25 2024 to consider and approve Unaudited Financial Results for the period ended December 31 2023 Outcome of the Board Meeting held on January 25, 2024 Outcome of Board Meeting held on Janauray 25, 2024 for declaration of Unaudited Financial resultd for the period ended December 31, 2023 and Reconctitution of Committees of the Board. (As per BSE Announcement Dated on 25/01/2024) | ||
Board Meeting | 6 Nov 2023 | 30 Oct 2023 |
Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Intimation of Board Meeting Scheduled to be held on Monday= November 06 2023 Outcome of Board Meeting held on Monday, November 06, 2023 Outcome of BM held on November 06, 2023 interalia to approve Unaudited Financial Statements (Standalone & Consolidated) for quarter & year ended September 30, 2023 Outcom of Board Meeting held on November 06, 2023 interalia to appoint Additional Director (in capacity of Independent Director) (As Per BSE Announcement Dated on 06.11.2023) | ||
Board Meeting | 3 Aug 2023 | 25 Jul 2023 |
Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2023 inter alia to consider and approve Board Meeting Intimation interalia to consider and approve the Un-audited Standalone and Consolidated Financial Results (under Ind-AS) for the quarter ended on June 30 2023. Outcome of Board Meeting held on August 03, 2023, approving Unaudited Financial Results for quarter ended June 30, 2023 Outcome of Board Meeting held on Augist 03, 2023 inter alia to approve Unaudited Financial Results for quarter ended June 30, 2023. (As Per BSE Announcement dated on 03.08.2023) |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.